Making pharmacogenomics a reality, with the Mayo Clinic
“Individualized or precision medicine offers help for your medical practice today. You can take advantage of these advances to help your patients, to better diagnose, treat or prevent illness right now.”
— Gianrico Farrugia, M.D, vice president and CEO of Mayo Clinic Florida
What is pharmacogenomics, and why is it important?
Pharmacogenomics, the study of how individual genetics influence the way that medicines work in the body, or ‘PGx’ as it is affectionately known, was highlighted by Gianrico Farrugia, M.D., vice president and CEO of Mayo Clinic Florida, as one of the key ways that precision medicine could impact healthcare. Speaking at last year’s Individualizing Medicine Conference, Dr Farrugia said, “Pharmacogenomics — prescribing medications based on a person’s genomic information — is helping physicians avoid harmful reactions. As Mayo has embedded its available patients’ genomic information in the electronic health record, more than 3500 adverse reactions have been prevented in the last two years.”
“Why is it important?”, is just one of the many questions that the Mayo Clinic Center for Individualized Medicine is looking to address this October, in Rochester, MN, at the Individualizing Medicine Conference: Advancing Care Through Genomics. At FLG we make no secret of the fact that we’re big cheerleaders for any efforts to deliver the benefits of genomics to patients faster, and so today we’re really happy to take a look at just some of the great clinical content ready to take the stage in Rochester later this year.
As a result, it is not surprising to see that pharmacogenomics has jumped to the front and centre of the Individualizing Medicine Conference agenda. On the plenary stage, Julie Johnson, Pharm.D., a recognised leader in cardiovascular pharmacogenomics and genomic medicine, will be leading the audience on a tour through her work to improve outcomes in clinical practice.
One barrier to clinical implementation of pharmacogenomics is the lack of freely available, peer-reviewed, updatable, and detailed gene/drug clinical practice guidelines. In an unprecedented collaboration, The Clinical Pharmacogenetics Implementation Consortium (CPIC), and the Dutch Pharmacogenetics Working Group (DPWG) converge to delve further into the application of PGx. Sessions will cover national and international perspectives on guidelines for pharmacogenomics, as well as how they develop guidelines that enable the translation of genetic laboratory test results into actionable prescribing decisions for specific drugs and apply CPIC and DPWG guidelines into clinical practice.
Finally, the opportunity to learn more about pharmacogenomics continues with a workshop on Friday, October 7. This is your opportunity to learn key take-home points from the world’s leaders in PGx. The aim of the workshop is to provide attendees with a half-day of practical guidance to implement pharmacogenomics in a variety of health care settings. To find out more about the Individualizing Medicine Conference, check out the conference website, and get the low down on all the speakers here.